Aoxing Signs Up New Partner to Co-Develop Novel Class of Molecules in Pain, Drug Addiction Therapeutics – Update

Viewpoints: Medi-Cal cuts are shortsighted: Methadone treatment pays off
Gov. Arnold Schwarzenegger ‘s budget proposes cutting Medi-Cal funding for methadone maintenance. The $53 million that would ostensibly be saved would, in fact, cost Californians a lot more.

Read more on The Sacramento Bee

Guest column: ‘Housing first’ best way to help the homeless
Before moving to Knoxville, I developed housing for the homeless and other low-income people in the Seattle area for 11 years. Based on my experience, I believe that the “housing first” model – which places people in safe, permanent housing without first requiring them to overcome their mental illness and/or addiction – is the right approach to serving chronically homeless people with …

Read more on Knoxville News Sentinel

Aoxing Signs Up New Partner To Co-develop Novel Class Of Molecules In Pain, Drug Addiction Therapeutics – Update
Thursday, Aoxing Pharmaceutical Co. (AXN) entered into a strategic alliance with privately held, clinical-stage Utah drug discovery company Phoenix PharmaLabs Inc. to co-develop a novel class of molecules in pain and drug addiction therapeutics.

Read more on RTT News